Correlation Between Pfizer and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Pfizer and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Pfizer and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ArriVent BioPharma,.
Diversification Opportunities for Pfizer and ArriVent BioPharma,
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pfizer and ArriVent is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Pfizer i.e., Pfizer and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Pfizer and ArriVent BioPharma,
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.62 times more return on investment than ArriVent BioPharma,. However, Pfizer Inc is 1.62 times less risky than ArriVent BioPharma,. It trades about -0.04 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about -0.07 per unit of risk. If you would invest 2,602 in Pfizer Inc on September 15, 2024 and sell it today you would lose (44.00) from holding Pfizer Inc or give up 1.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Pfizer Inc vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Pfizer Inc |
| ArriVent BioPharma, |
Pfizer and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and ArriVent BioPharma,
The main advantage of trading using opposite Pfizer and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
| ArriVent BioPharma, vs. Aegon NV ADR | ArriVent BioPharma, vs. Minerals Technologies | ArriVent BioPharma, vs. Western Digital | ArriVent BioPharma, vs. United States Steel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |